Conférences  >  Médecine & Soins de Santé  >  Cancérologie

Researchers Fuzion

Tél.: [+1 209 759 0413];     Email.: aarongladd36@gmail.com

Hematology and Cardio-Oncology, Neuro-Hematology, Organ Specific Cancer, Cancer Genomics & Metabolomics

The European Association for Cancer Research (EACR), with support from The Organisation of European Cancer Institutes (OECI)

This virtual event will explore how meaningful involvement of cancer advocates throughout the research process can lead to impactful cancer research. We will highlight practical examples and offer insights into how researchers, clinicians, and patient advocates can work together to bridge gaps between science and cancer care. Participants will better understand the opportunities and challenges in shaping a collaborative research culture to advance research and improve cancer care.

Chris Iliffe (Conference Officer);     Tél.: [N/A];     Email.: christopher.iliffe@eacr.org

cancer research, oncology, cancer patients, patient perspective, patient advocacy, cancer care, cancer treatment, patient quality of life, cancer symptom management, cancer therapy side effects, innovative therapy development, collaborative research

Médecine translationnelle, essais cliniques,    Génie biomédical

Forum für medizinische Fortbildungen (FOMF)

Zertifizierte Fortbildung für ÄrztInnen der Onkologie (Gastrointestinal) via Livestream, 29. Oktober 2025. Updates & die neusten Leitlinien. 3 CME-Punkte wurden bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!

Medical Unit;     Email.: medical-team@fomf.org

Formation médicale continue (FMC),    Gastro-entérologie

Thomas Jefferson University

Updates in Medical Oncology will provide a review of recent developments in the therapy of cancers and related diseases. Disease area experts will use a case-based approach to discuss the use of emerging therapies in the clinical arena, including a discussion of the practical aspects of therapy, supportive care, and therapy-related toxicities. Attendees will have the opportunity to participate in disease area roundtable discussions on the current state of the art for specific malignancies, along with active clinical trials.

Email.: jeffersoncpd@jefferson.edu

Medical Oncology, Radiation, Surgery, Cancer Therapy

The European Association for Cancer Research (ECAR)

event lab. GmbH

Im Herzen des Ruhrgebiets vereinen wir die Expertise von sieben kinderchirurgischen Fachabteilungen, um einen praxisnahen und innovativen Austausch auf höchstem Niveau zu fördern. Unser Konsortium spiegelt die Vielfalt und Stärke der kinderchirurgischen Versorgung wider – von universitären Spitzenzentren bis hin zu renommierten Lehrkrankenhäusern. Wir freuen uns darauf, Sie an einem zentralen Veranstaltungsort begrüßen zu dürfen, um gemeinsam die Zukunft der Kinderchirurgie zu gestalten und weiter voranzutreiben.

Tabea Just, event lab. GmbH;     Tél.: [+49 341 30 88 84 67];     Email.: akic@eventlab.org

Kinderchirurgie, Pädiatrie, Chirurgie, Kinderarzt, Kinderärzte, Urologie, Gynäkologie, Onkologie, Neonatologie, Austausch, Fortbildung, Austausch

Pédiatrie, Néonatalogie,    Gynécologie/obstétrique

The European Association for Cancer Research (EACR) and The Mark Foundation for Cancer Research

Early-onset cancers are rising globally. Cancers typically associated with those over the age of 50 are increasingly being diagnosed in young adults. How to prevent and treat these tumours is still unknown. This conference aims to foster a deeper understanding of the biological mechanisms, risk factors, and clinical implications of early-onset cancers. By bringing together leading experts from diverse fields in cancer research, the meeting will provide a unique platform to discuss the latest discoveries about early-onset cancers, promoting interdisciplinary collaboration and identifying strategies for early detection, prevention, and treatment. Special attention will be given to knowledge gaps, translational studies and healthcare disparities, and towards improving the clinical management of early-onset cancer patients. The target audience for this conference is researchers and physicians who are interested in the epidemiology and aetiology of sporadic cancers among younger adults to discuss key questions in the field and lay the foundations for generating a community dedicated to the study of early-onset cancers.

Conference Officer, Hannah Barrs;     Tél.: [N/A];     Email.: hannah.barrs@eacr.org

cancer research, oncology, early-onset cancers, biological mechanisms of cancer, cancer risk factors, clinical implications, early detection, prevention, cancer treatment, cancer therapies, healthcare disparities, translational cancer research, clinical management of cancer patients, cancer epidemiology, cancer aetiology, molecular pathology, exposome changes, cancer microbiome, cancer immunity, the tumour microenvironment, carcinogenesis, cancer epigenetics, preclinical experimental models, microsimulation modelling, cancer, cancer survivorship.

Biologie moléculaire,    Biologie des systèmes

EMBL Heidelberg

This meeting will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. We aim to bring together scientists from across several disciplines connected with cancer research, for a unique opportunity to interact and stimulate further integration of these efforts.

EMBL Events;     Email.: events@embl.de

Forum für medizinische Fortbildungen (FOMF)

Zertifizierte Fortbildung für ÄrztInnen der Hämatologie und Onkologie vor Ort in Stuttgart, 14.-15. November 2025. Updates & die neuesten Leitlinien. 16 CME-Punkte sind bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!

Medical Unit;     Email.: medical-team@fomf.org

Formation médicale continue (FMC),    Hématologie

Mathews International LLC

The International Cancer Science and Research Conference 2025 scheduled for November 17-19, 2025, in Singapore, promises to be a pivotal event in the field of oncology. Held under the theme "Revolutionizing Cancer Care: Innovations and Collaborations for a Healthier Future," this hybrid event will welcome both onsite and virtual attendees, ensuring global accessibility. As one of the most anticipated Cancer Conferences of the year, it will unite leading oncologists, researchers, and healthcare professionals to advance the fight against cancer. This Oncology Conference will highlight ground breaking advancements in cancer prevention, diagnostics, and treatment, with key discussions focusing on areas such as immunotherapy, precision medicine, and targeted therapies. Participants in the Cancer Conferences 2025 will have the chance to share insights, foster collaborations, and explore innovative approaches to improving patient outcomes. Don’t miss this unparalleled opportunity to contribute to the future of cancer care—register now!

Tél.: [+13124624448];     Email.: cancer@mathewsconference.com

Cancer Conferences, Cancer Conferences 2025, Cancer Science and Research Conference, Oncology Conference, Radiology Conference, Oncology Conferences, Radiology Conferences, Oncology Events, Cancer Events, Oncology Conferences 2025, Cancer Congress, Cancer Hybrid Events, Cancer Webinars, Cancer Seminars, Cancer Meetings, Cancer Workshops, Cancer Virtual Conference, Cancer Symposium, Cancer Online Event, Cancer Hybrid Event, Cancer Summit, Cancer Expo, Upcoming Cancer Conference, International Cancer Conferences, Global Cancer Congress, Cancer Hybrid Webinar, Cancer Hybrid Seminar, International Conference on Cancer, Global Congress on Cancer, International Summit on Cancer, Cancer Seminar, Cancer Meeting, Cancer Workshop, Upcoming Cancer Congress, Upcoming Cancer Event, Cancer Event, Cancer Conference in USA, Cancer Congress in Europe, Cancer Meeting in Italy, Cancer Seminar in UK, Cancer Event in London, Cancer Workshop in Spain, Cancer Hybrid Event in Paris, Cancer Virtual conference in France, Top Cancer Conference, Top 10 Cancer Symposiums

This free, publicly available webinar is hosted by the EACR in association with the Young European Hematology Association (yEHA) and the Young European Federation of Immunological Societies (yEFIS).

The webinar will discuss the potential of CAR T-cells for the treatment of hematological malignancies and solid tumours.

The European Association for Cancer Research (ECAR)

Forum für medizinische Fortbildungen (FOMF)

Zertifizierte Fortbildung für ÄrztInnen der Hämatologie und Onkologie vor Ort in Berlin & via Livestream, 28.-29. November 2025. Updates & die neuesten Leitlinien. 16 CME-Punkte sind bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!

Medical Unit;     Email.: medical-team@fomf.org

Formation médicale continue (FMC),    Hématologie

Forum für medizinische Fortbildungen (FOMF)

Zertifizierte Fortbildung für ÄrztInnen der Onkologie in Wien und via Livestream, 29.11.2025. Updates & die neusten Leitlinien. 7 DFP-Punkte wurden bei den zuständigen Ärztekammern angefragt. Jetzt informieren & buchen!

Medical Unit;     Email.: medical-team@fomf.org

The European Association for Cancer Research (EACR)

This conference will explore the fundamental mechanisms controlling cancer cell plasticity at multiple biological levels including the epigenome, transcriptome, metabolome, and cellular microenvironment. Our panel of expert speakers will also discuss innovative approaches to target cell plasticity using novel pharmacological interventions that aim to prevent or reverse the adaptive mechanisms cancer cells use to circumvent conventional therapies.

Chris Iliffe (Conference Officer);     Tél.: [N/A];     Email.: christopher.iliffe@eacr.org

cancer research, oncology, cancer cell biology, cancer cell plasticity, cancer epigenetics, cellular microenvironment, tumour microenvironment, tumour heterogeneity, cancer transcriptomics, metabolic reprogramming in cancer, phenotypic changes in cancer, cancer progression, cancer therapy resistance, virtual academic conference

Biologie moléculaire,    Médecine translationnelle, essais cliniques

Forum für medizinische Fortbildungen (FOMF)

Zertifizierte Fortbildung für ÄrztInnen der Hämatologie und Onkologie vor Ort in Köln & via Livestream, 12.-13. Dezember 2025. Updates & die neuesten Leitlinien. 16 CME-Punkte sind bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!

Medical Unit;     Email.: medical-team@fomf.org

Formation médicale continue (FMC),    Hématologie

European Society For Medical Oncology

The Best of ESMO 2025 highlights key breakthroughs in oncology, focusing on precision medicine, immunotherapy, and innovative cancer treatments that aim to improve patient outcomes worldwide.

Sushma;     Tél.: [+91 9731853344];     Email.: esmoindia@globalhealthcareacademy.in

Oncology conference, cancer research, clinical oncology, immunotherapy, targeted therapy, precision medicine, cancer treatment updates, oncology breakthroughs, clinical trials, biomarker research, molecular oncology, cancer care, medical oncology, oncology innovation, multidisciplinary oncology, evidence-based medicine, oncology education, global cancer care.

The European Association for Cancer Research (EACR)

This conference will explore a seemingly paradoxical approach to cancer therapy: the deliberate hyper-activation of cancer-relevant signalling pathways. Accumulating evidence suggests that this leads to cell death caused by a further activation of cellular stress responses. Such an approach could revolutionise treatment strategies, which often cannot abate the return of resistance in advanced cancers caused by secondary mutations reactivating previously inhibited pathways. Join us on 20 and 21 January 2026 to learn the latest science in this field from our panel of globally renowned experts. They will teach you about ways to hyperactivate oncogenic signalling and how the vulnerabilities associated with this state can be identified. In doing so, you’ll gain a fundamentally different perspective on ways to treat cancer. If you work in this field, send us an abstract before 17 November 2025 for a chance to have your work featured as a Proffered Paper or in a Flash Talk presentation! Registration closes on 15 December 2025.

Conference Officer: Chris Iliffe;     Tél.: [N/A];     Email.: christopher.iliffe@eacr.org

cancer research, oncology, inhibiting oncogenic signalling, cancer therapy resistance mechanisms, secondary mutations in cancer, novel cancer therapy approaches, hyperactivation of signalling pathways, vulnerabilities within hyperactivated cancer cells, drug application, novel target identification

European Association for the Study of the Liver (EASL)

Rapid advancements in hepatocellular carcinoma and cholangiocarcinoma are transforming treatment strategies, with immunotherapy, new systemic therapies, and AI-driven diagnostics reshaping the field. This summit offers a unique opportunity to engage with experts across disciplines, explore the latest in basic, translational, and clinical research, and address evolving standards in personalised care. Join the global liver cancer community in Edinburgh from 22–24 January 2026.

Liver tumours

Keystone Symposia

This conference focuses attention on the cancer cell itself, exploring the cell-intrinsic mechanisms that drive carcinogenesis and cancer progression. The meeting emphasizes understanding how genetic, epigenetic, and metabolic changes within cancer cells contribute to tumor evolution, heterogeneity, and plasticity, in order to provide new insights into potential strategies for therapeutic interventions. While other meetings in the field focus on the tumor microenvironment and crosstalk between cells within the tumor, this meeting will take a distinct approach to pinpoint cancer cell vulnerabilities, and therapeutic strategies targeting intrinsic pathways. By bringing together experts from academia, industry, and medicine to examine the underpinnings of tumor development and evolution, we will inspire new approaches to cancer treatment.

The European Association for Cancer Research (EACR)

This conference will focus on the basic mechanisms controlling cancer cell signalling circuits at the transcriptome, proteome and phosphoproteome levels, as well as emerging concepts in cancer cell signalling and cutting-edge, OMICS-based insights. Despite decades of research, our global understanding of how cancer cell signalling circuits are controlled, and how they determine cancer progression and therapy resistance, is still far from complete. Join us online on 10 and 11 February 2026 to hear the latest science in this area from a panel of global experts. If you work in this field, submit an abstract before 15 December 2025 for a chance to have your work featured as a Proffered Paper or in a Flash Talk presentation. Register by 19 January 2026 to secure your place as a participant.

Conference Officer: Hannah Barrs;     Email.: hannah.barrs@eacr.org

cancer research, oncology, cancer cell signalling, cell signalling networks, cell signalling control mechanisms, cancer progression, cancer therapy resistance, post-translational protein regulation, transcriptional gene regulation, transcriptomics, proteomics, phosphoproteomics, kinases and phosphatases, signalling rewiring, signal integration, RNA biology in cancer

Deutsche Krebsgesellschaft e. V. und Stiftung Deutsche Krebshilfe

Motto: zusammen - gezielt - zukunftsfähig

Gemeinsame Gespräche mit Beteiligten aus Medizin, Pflege, Politik und unter enger Einbindung der Betroffenenorganisationen über die Onkologie der Zukunft mit einem ganzheitlichen Blick auf eine patientenzentrierte Forschung und Versorgung. Eine hohe Priorität hat auch die konsequente Nachwuchsförderung. Auch geht es um Chancen und Grenzen der künstlichen Intelligenz, Fragen der Versorgungsgerechtigkeit und die Herausforderungen einer zunehmenden Vielfalt der Betroffenen.

Tél.: [030 3229329-18];     Email.: dkk@krebsgesellschaft.de

Onkologie der Zukunft, gezielter Einsatz von Ressourcen, Versorgungsgerechtigkeit und Vielfalt in der Krebsmedizin, Partizipation/Stimmen der Betroffenen, Cancer Survivor, Palliativmedizin, u.v.m.

The European Association for Cancer Research (EACR)

Join us online on 24 and 25 February 2026 to explore cutting-edge developments in immunotherapy, ranging from basic research to clinical applications, with a particular focus on innovative therapeutic strategies. The programme will include invited talks from leading scientists in areas such as novel NK, T and myeloid cell therapies, mRNA therapies, and new combinatorial immune checkpoint blockade strategies. It will provide a broad overview and detailed knowledge of novel targets and new therapeutic strategies in this field. If your work centres on any of the topics mentioned above, you may be able to present it at our conference! Submit an abstract by 12 January 2026 for a chance to have your work featured as a Proffered Paper or in a Flash Talk presentation! Participant registration closes on 02 February 2026.

Conference Officer: Chris Iliffe;     Email.: christopher.iliffe@eacr.org

cancer research, oncology, cancer immunotherapy, next-gen approaches to cancer therapies, cancer resistance, overcoming cancer resistance, novel NK cell therapy, novel T-cell therapy, novel myeloid cell therapy, mRNA therapy, cytokine targeting, personalised immunotherapies, basic cancer research, translational cancer research, pre-clinical cancer research, clinical applications

ESMO - European Society for Medical Oncology

The ESMO Sarcoma and Rare Cancers Congress 2026 will once again serve as a premier forum for sharing groundbreaking research, novel treatment strategies, and fostering collaborations to drive progress in this crucial area of oncology. Join us from 12–14 March 2026 in the charming city of Lugano, Switzerland, renowned for its stunning lakeside views and rich cultural heritage. The scientific and educational programme will explore the latest advancements in diagnosis, treatment, biology, and molecular classification of rare solid tumours, ensuring a comprehensive update on the evolving landscape of these complex diseases. Attendees can engage in Abstract-related sessions, educational lectures, Multidisciplinary Tumour Boards, Special Sessions, Guidelines discussions, and dedicated Young Oncologists sessions, all designed to enhance knowledge and foster interactive discussions. Whether you are a clinician, researcher, healthcare professional, industry expert, or patient advocate, this congress offers a unique opportunity to connect, learn, and contribute to the future of sarcoma and rare cancer care.

ESMO Meetings Operations Team;     Tél.: [+41 91 97 31 946];     Email.: meetings@esmo.org

Sarcoma biology, Rare cancers, Tumour microenvironment, Molecular diagnostics, Genomic profiling, Precision oncology, Biomarkers of response, Immunotherapy in sarcomas, Targeted therapy, Novel drug development, Clinical trials phase I, Clinical trials phase II, Clinical trials phase III, Multimodal therapy, Resistance mechanisms, Long-term survivorship, Real-world evidence, Surgery, Radiation therapy, Systemic therapy, Chemotherapy, Targeted agents, Immunomodulators, CAR T-cell therapy, Checkpoint inhibitors, Antiangiogenic therapy, Gene therapy, Combination therapies, Soft tissue sarcoma, Bone sarcoma, GIST, Liposarcoma, Leiomyosarcoma, Undifferentiated pleomorphic sarcoma, Ewing sarcoma, Osteosarcoma, Rhabdomyosarcoma, Synovial sarcoma, Rare mesenchymal tumours, Quality of life, Patient-reported outcomes, Survivorship, Toxicity management, Side effects, Late effects, Palliative care, Patient access, Health equity, Cost effectiveness, Health policy, Imaging techniques, MRI, PET-CT, Functional imaging, Liquid biopsy, Bioinformatics, AI, Single-cell sequencing, Molecular subtyping, Pathology standards, Abstract submission, Late breaker, Keynote lecture, Workshops, Poster sessions, Multidisciplinary teams, Collaborative networks, Guidelines, Consensus statements, Regulatory framework

Biologie médicale,    Chirurgie

Keystone Symposia

While immunotherapies have transformed cancer treatment, they only benefit a subset of patients, with many failing to respond or quickly developing resistance. This Keystone Symposia will examine the limitations of immunotherapies, the reasons for failure and mechanisms of resistance, in order to guide strategies to overcome these hurdles and improve clinical outcomes.

European Society for Medical Oncology (ESMO)

The journey of innovation in cancer treatment begins with early drug development. ESMO TAT serves as a dynamic, multi-stakeholder forum, uniting researchers, industry leaders, investors and regulators under one roof to accelerate the delivery of life-changing anticancer therapies to patients. Join us in the pursuit to advance cancer treatment: we look forward to seeing you at this transformative event, to share new data, foster collaboration, and tackle challenges that will drive early clinical development forward.

The European Association for Cancer Research (EACR)

Designing efficient novel therapeutics cannot be achieved without understanding the dynamics of the tumour microenvironment or of reciprocal cancer-stroma interactions and how they are modulated by cancer treatments. With this in mind, the second edition of this conference topic will cover the latest exciting breakthroughs in this field. Specialist themes include the intricate interactions of cancer cells with the immune system and with specific stromal cells in multiple organs, novel insights into tumour-host interactions including the nervous system, and response to therapy. If you’re interested in translational cancer biology, immunology, and therapeutics – whether you’re a scientist, postdoc, graduate student, industry scientist, or journal editor – then this conference is not to be missed. Submit your application by 19 January 2026 for the chance to present your work and register by 16 February 2026 to join us in Bergamo.

Conference Officer: Hannah Barrs;     Email.: hannah.barrs@eacr.org

cancer research, oncology, tumour microenvironment, novel therapeutics, cancer cells, stromal cells, cancer-stroma interactions, cancer immunology, tumour-host interactions, treatment response

Keystone Symposia

This Keystone Symposia Conference will explore interactions between tumor cells and their surrounding microenvironment, examining both tumor-intrinsic and -extrinsic signaling programs that influence cancer progression and systemic host responses such as aging, cachexia, obesity, and immunity.

The European Association for Cancer Research (ECAR)

The European Association for Cancer Research (EACR)

The 7th edition of this extremely popular conference topic will be held in Essen, Germany on 12-14 May 2026. It will showcase the latest breakthroughs in cancer genomics, multiomics, and computational biology, covering topics including machine learning and artificial intelligence, single-cell and spatial analysis of cancers, cell plasticity, cancer immune genomics, data integration and convergence, epigenetics, and genomic instability. If your work centres on any of these topics, you may be able to present it at our conference! Submit an abstract by 16 March 2026 for a chance to have your work featured as a Proffered Paper or in a Flash Talk presentation! Participant registration closes on 13 April 2026.

Conference Officer: Chris Iliffe;     Email.: christopher.iliffe@eacr.org

cancer research, oncology, cancer genomics, cancer multiomics, computational cancer biology, machine learning, artificial intelligence, single-cell analysis, spatial analysis, cancer cell plasticity, cancer immune genomics, data integration and convergence, cancer epigenetics, genomic instability, molecular pathology, cancer evolution, immune evasion, bioinformatics, systems biology, translational cancer research

Biologie des systèmes,    Génomique et bio-informatique

The European Association for Cancer Research (ECAR)

The 2026 Annual Congress of the European Association for Cancer Research (EACR 2026) is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.

Keystone Symposia

The meeting will bring together disparate fields to consider the tumor in the context of the entire organism, broadening the scope and complexity of cancer metabolism research to generate novel insights with clinical impacts. By bringing together scientists and clinicians across siloed fields, we aim to inspire cross-disciplinary collaborations that will yield transformative treatment strategies and accelerate clinical advances.

The 5th SCPSC will feature an innovative program reflecting the evolving fields of palliative oncology and psycho-oncology, uniting leading researchers from around the world. Palliative care is entering a new era of research and clinical practice.

The European Association for Cancer Research (ECAR)

The EACR Conference on Chromosomes in Crisis: From Chromosomal Instability to Catastrophes in Cancer Genomes will bring together leading experts to explore the mechanisms, consequences, and therapeutic vulnerabilities associated with these genomic rearrangements. Join us in Berlin, Germany, to uncover how chromosomal chaos shapes cancer biology and opens new avenues for clinical intervention.

European Association for the Study of the Liver (EASL)

Liver tumours